The claim period has now passed (June 27, 2024)
A settlement was approved in the Canadian Oxycontin Class Actions. The Claims Administrator is currently analyzing and processing the claims filed. A notice of decision will be sent to individuals, or their respective law firms, that filed a claim once the claims analysis is complete.
For more information, please visit www.oxycontinclassactionsettlement.ca
A Canada-wide settlement has been approved to settle several Canadian class actions relating to the prescription drugs OxyContin and OxyNEO, including cases filed by Siskinds LLP and Siskinds, Desmeules. The Settlement will compensate eligible class members for various injuries that they suffered due to addictions that they developed from using these prescription Oxy drugs.
The Canadian OxyContin Class Action Settlement is now open to claims. Anyone who was prescribed and ingested OxyContin and/or OxyNEO in Canada between January 1, 1996, and February 28, 2017, was eligible to claim under the settlement. Estates of deceased Canadian Oxy users were also eligible to file claims, as are spouses, children, and certain other family members. Class members had until June 27, 2024, to file a claim.
For more information, please read the Notice of Settlement Approval, or visit the Canadian OxyContin Class Action Settlement website at: www.oxycontinclassactionsettlement.ca or contact the claims administrator at 1.888.663.7185 or [email protected].
Developments
On June 8, 2007, the law firms of Rochon Genova LLP and Siskinds LLP filed a class action on behalf of all persons in Canada (excluding Quebec) who were prescribed and ingested Oxycontin against the manufacturers of the drug, Purdue Pharma and various affiliated entities. On May 11, 2007, Siskinds’ Québec-based affiliate, Siskinds Desmeules, also filed a similar action on behalf of Québec residents. Various other law firms in Canada also filed prospective OxyContin class actions.
In 2017, the parties to various class actions (including Siskinds’ class actions) reached a Settlement Agreement to resolve the Oxycontin class action litigation across Canada. In 2017, this agreement was approved in Ontario, Quebec and Nova Scotia. In 2022, the settlement was approved in Saskatchewan.
The Canadian OxyContin Class Action Settlement received the required court approvals.
Anyone who was prescribed and ingested OxyContin and/or OxyNEO in Canada between January 1, 1996, and February 28, 2017, was eligible to claim under the settlement, including estates of Canadian Oxy users who have since passed away. Spouses, children, and certain other family members of approved claimants were also eligible to make claims. Class members had until June 27, 2024 to submit a claim.
For more information, please read the Notice of Settlement Approval. Class members’ rights under the Settlement are explained in the notice.
For all other details on the Settlement, visit the Canadian OxyContin Class Action Settlement website at: www.oxycontinclassactionsettlement.ca or contact the claims administrator at 1.888.663.7185 or [email protected].
FAQs
What is a class action?
A class action is a lawsuit that is brought by one or more persons on behalf of a larger group of people whose claims share common legal and/or factual issues. Class actions provide a cost-effective way for groups of
How do I participate in the class action settlement?
Class Members were permitted to file their own claims to the Canadian OxyContin Class Action Settlement, or they could retain a lawyer to do so on their behalf.
If a Class Member retained Class Counsel to assist them in making an individual claim for compensation to the Canadian OxyContin Class Action Settlement, Class Counsel have agreed to cap their fees at 15% of the amount awarded to the Class Member.
The claim period ended on June 27, 2024.
For all details on the Settlement, visit the Canadian OxyContin Class Action Settlement website at: www.oxycontinclassactionsettlement.ca
Who is affected by the Oxycontin class action?
You are affected by the class action and are a “member” of the class if you were prescribed and ingested Oxycontin, and/or OxyNEO in Canada between January 1, 1996, and February 28, 2017. Estates of deceased Canadian Oxy users are also eligible to file claims, as are certain people who were family members of class members during their periods of addiction, including spouses, common law spouses, children, grandchildren, parents, and siblings.
I still have a question. Who should I contact?
For more information, contact the claims administrator at 1.888.663.7185 or [email protected].
You can also email Siskinds LLP at [email protected], call us toll-free at 1.800.461.6166, or complete the form on this page.
Documents
Quebec:
- Settlement Approval Order - Quebec Superior Court - August 17, 2017 (French only)
- Certification for settlement purposes - Quebec Superior Court - April 4, 2017 (French only)
- Amended application to institute a class action - February 20, 2008 (French Only)
- Application to institute a class action - May 11, 2007 (French Only)
Nova Scotia:
- Settlement Approval Order - Supreme Court of Nova Scotia - July 19, 2017 (English only)
Ontario:
- Settlement Approval Order - Superior Court of Justice – July 19, 2017 (English only)
- Order of Justice Strathy- Superior Court of Justice –December 24, 2017 (English only)
Saskatchewan:
- Settlement Approval Order – Court of King’s Bench – September 23, 2022 (English only)
Agreements and notices:
- Settlement Agreement
- Notice of Settlement [English] [French]